Real-time enrollment status for this esophageal cancer clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 5:21 AM UTC
| NCT Number | NCT03801876 |
| Recruiting Status | Recruiting |
| Condition | Esophageal Cancer |
| Phase | PHASE3 |
| Target Enrollment | 300 participants |
| Active Locations | 96 sites in the US |
| Sponsor | NRG Oncology |
| Last Updated on CT.gov | June 25, 2026 (3 weeks ago) |
As of July 18, 2026: Clinical trial NCT03801876 is currently recruiting participants. This phase3 study for esophageal cancer is actively seeking new participants at 96 locations across the United States. The study is sponsored by NRG Oncology. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03801876 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 96 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03801876 was last updated 3 weeks ago (June 25, 2026). HelloStudys verifies this status automatically.